OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A perspective on SARS-CoV-2 virus-like particles vaccines
Gao Xiaoyang, Yeting Xia, Xiaofang Liu, et al.
International Immunopharmacology (2023) Vol. 115, pp. 109650-109650
Open Access | Times Cited: 15
Gao Xiaoyang, Yeting Xia, Xiaofang Liu, et al.
International Immunopharmacology (2023) Vol. 115, pp. 109650-109650
Open Access | Times Cited: 15
Showing 15 citing articles:
Nanovaccines: A game changing approach in the fight against infectious diseases
Priyanka Choudhary, Mai Abdel Haleem Abusalah, Hitesh Chopra, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115597-115597
Open Access | Times Cited: 46
Priyanka Choudhary, Mai Abdel Haleem Abusalah, Hitesh Chopra, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115597-115597
Open Access | Times Cited: 46
Laser wavelength and sample conditioning effects on biochemical monitoring of SARS-CoV-2 VLP production upstream stage by Raman spectroscopy
Felipe Moura Dias, Júlia Públio Rabello, Luis Giovani Oliveira Guardalini, et al.
Biochemical Engineering Journal (2024) Vol. 211, pp. 109441-109441
Closed Access | Times Cited: 2
Felipe Moura Dias, Júlia Públio Rabello, Luis Giovani Oliveira Guardalini, et al.
Biochemical Engineering Journal (2024) Vol. 211, pp. 109441-109441
Closed Access | Times Cited: 2
Study of the Effects of Several SARS-CoV-2 Structural Proteins on Antiviral Immunity
Rong Yue, Fengyuan Zeng, Danjing Ma, et al.
Vaccines (2023) Vol. 11, Iss. 3, pp. 524-524
Open Access | Times Cited: 5
Rong Yue, Fengyuan Zeng, Danjing Ma, et al.
Vaccines (2023) Vol. 11, Iss. 3, pp. 524-524
Open Access | Times Cited: 5
Rapid and Scalable Production of Functional SARS-CoV-2 Virus-like Particles (VLPs) by a Stable HEK293 Cell Pool
Sitthiphol Puarattana-aroonkorn, Kannan Tharakaraman, Disapan Suriyawipada, et al.
Vaccines (2024) Vol. 12, Iss. 6, pp. 561-561
Open Access | Times Cited: 1
Sitthiphol Puarattana-aroonkorn, Kannan Tharakaraman, Disapan Suriyawipada, et al.
Vaccines (2024) Vol. 12, Iss. 6, pp. 561-561
Open Access | Times Cited: 1
Beta Spike-Presenting SARS-CoV-2 Virus-Like Particle Vaccine Confers Broad Protection against Other VOCs in Mice
Irfan Ullah, Kelly Symmes, Kadiatou Keita, et al.
(2024)
Open Access | Times Cited: 1
Irfan Ullah, Kelly Symmes, Kadiatou Keita, et al.
(2024)
Open Access | Times Cited: 1
Viral vector- and virus-like particle-based vaccines against infectious diseases: A minireview
Ruth Henríquez, Isabel Muñoz‐Barroso
Heliyon (2024) Vol. 10, Iss. 15, pp. e34927-e34927
Open Access | Times Cited: 1
Ruth Henríquez, Isabel Muñoz‐Barroso
Heliyon (2024) Vol. 10, Iss. 15, pp. e34927-e34927
Open Access | Times Cited: 1
Fc-empowered exosomes with superior epithelial layer transmission and lung distribution ability for pulmonary vaccination
Meng Fan, Haonan Xing, Jingru Li, et al.
Bioactive Materials (2024) Vol. 42, pp. 573-586
Closed Access | Times Cited: 1
Meng Fan, Haonan Xing, Jingru Li, et al.
Bioactive Materials (2024) Vol. 42, pp. 573-586
Closed Access | Times Cited: 1
Virus-like particles (VLPs)-based vaccines against COVID-19: Where do we stand amid the ongoing evolution of SARS-CoV-2?
Manish Dhawan, AbdulRahman A. Saied, Manish Sharma
Health Sciences Review (2023) Vol. 9, pp. 100127-100127
Open Access | Times Cited: 4
Manish Dhawan, AbdulRahman A. Saied, Manish Sharma
Health Sciences Review (2023) Vol. 9, pp. 100127-100127
Open Access | Times Cited: 4
Both recombinant Bacillus subtilis Expressing PCV2d Cap protein and PCV2d-VLPs can stimulate strong protective immune responses in mice
Yuxuan Zhang, Yao Wu, Chong Peng, et al.
Heliyon (2023) Vol. 9, Iss. 12, pp. e22941-e22941
Open Access | Times Cited: 3
Yuxuan Zhang, Yao Wu, Chong Peng, et al.
Heliyon (2023) Vol. 9, Iss. 12, pp. e22941-e22941
Open Access | Times Cited: 3
Beta Spike-Presenting SARS-CoV-2 Virus-like Particle Vaccine Confers Broad Protection against Other VOCs in Mice
Irfan Ullah, Kelly Symmes, Kadiatou Keita, et al.
Vaccines (2024) Vol. 12, Iss. 9, pp. 1007-1007
Open Access
Irfan Ullah, Kelly Symmes, Kadiatou Keita, et al.
Vaccines (2024) Vol. 12, Iss. 9, pp. 1007-1007
Open Access
A substitution at the cytoplasmic tail of the spike protein enhances SARS-CoV-2 infectivity and immunogenicity
Yuhan Li, Xianwen Zhang, Wanbo Tai, et al.
EBioMedicine (2024) Vol. 110, pp. 105437-105437
Closed Access
Yuhan Li, Xianwen Zhang, Wanbo Tai, et al.
EBioMedicine (2024) Vol. 110, pp. 105437-105437
Closed Access
Current Advances in Viral Nanoparticles for Biomedicine
Xianxun Sun, Tao Tian, Yindong Lian, et al.
ACS Nano (2024)
Closed Access
Xianxun Sun, Tao Tian, Yindong Lian, et al.
ACS Nano (2024)
Closed Access
Immunogenicity and safety of SARS-CoV-2 recombinant protein vaccine (CHO cell) LYB001 as a heterologous booster following two- or three-dose inactivated COVID-19 vaccine in adults aged ≥18 years: interim results of a randomized, active-controlled, double-blinded, phase 3 trial
Beifang Yang, Jing Jin, Xiran He, et al.
Expert Review of Vaccines (2024)
Open Access
Beifang Yang, Jing Jin, Xiran He, et al.
Expert Review of Vaccines (2024)
Open Access
COVID-19 Vaccine in Renal Transplant Recipients: A Bibliometric-Based Analysis of Trends
Dong Wang, Chuan Zhou, Chao Wang, et al.
Transplantation Proceedings (2023) Vol. 55, Iss. 8, pp. 1771-1783
Open Access | Times Cited: 1
Dong Wang, Chuan Zhou, Chao Wang, et al.
Transplantation Proceedings (2023) Vol. 55, Iss. 8, pp. 1771-1783
Open Access | Times Cited: 1
The Global Impact of COVID-19: Historical Development, Molecular Characterization, Drug Discovery and Future Directions
Aboagye Kwarteng Dofuor, Naa Kwarley-Aba Quartey, Angelina Fathia Osabutey, et al.
Clinical Pathology (2023) Vol. 16
Open Access | Times Cited: 1
Aboagye Kwarteng Dofuor, Naa Kwarley-Aba Quartey, Angelina Fathia Osabutey, et al.
Clinical Pathology (2023) Vol. 16
Open Access | Times Cited: 1
